Terms: = Liver cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716 AND Treatment
49 results:
1. Inhibition of SIRT7 promotes STAT1 activation and STAT1-dependent signaling in hepatocellular carcinoma.
Dong L; Wei X; Yu L; Li Y; Chen L
Cell Signal; 2024 Feb; 114():111005. PubMed ID: 38070755
[TBL] [Abstract] [Full Text] [Related]
2. Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.
Liang X; Gao H; Xiao J; Han S; He J; Yuan R; Yang S; Yao C
Front Immunol; 2023; 14():1185985. PubMed ID: 37334368
[TBL] [Abstract] [Full Text] [Related]
3. Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature.
Sheng J; Pan H; Han W
Front Immunol; 2023; 14():1181444. PubMed ID: 37153561
[TBL] [Abstract] [Full Text] [Related]
4. Sunitinib suppresses M2 polarization of macrophages in tumor microenvironment to regulate hepatocellular carcinoma progression.
Kong Y; Guo L
J Biochem Mol Toxicol; 2023 Jun; 37(6):e23333. PubMed ID: 36797997
[TBL] [Abstract] [Full Text] [Related]
5. A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis.
Yu X; Ma H; Li B; Ji Y; Du Y; Liu S; Li Z; Hao Y; Tian S; Zhao C; Du Q; Jin Z; Zhu X; Tian Y; Chen X; Sun X; Yang C; Zhu F; Ju J; Zheng Y; Zhang W; Wang J; Yang T; Wang X; Li J; Xu X; Du S; Lu H; Ma F; Zhang H; Zhang Y; Zhang X; Hu S; He S
Blood; 2023 Mar; 141(9):1070-1086. PubMed ID: 36356302
[TBL] [Abstract] [Full Text] [Related]
6. The double-edged sword of probiotic supplementation on gut microbiota structure in
Nabavi-Rad A; Sadeghi A; Asadzadeh Aghdaei H; Yadegar A; Smith SM; Zali MR
Gut Microbes; 2022; 14(1):2108655. PubMed ID: 35951774
[TBL] [Abstract] [Full Text] [Related]
7. Ethanolic extract of Coleus aromaticus leaves impedes the proliferation and instigates apoptotic cell death in liver cancer HepG2 cells through repressing JAK/STAT cascade.
Shekh R; Tiwari RK; Ahmad A; Ahmad I; Alabdallah NM; Saeed M; Ansari IA; Mishra A; Ashfaque M; Bajpai P
J Food Biochem; 2022 Oct; 46(10):e14368. PubMed ID: 35945689
[TBL] [Abstract] [Full Text] [Related]
8. Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis.
Yi G; Huang Z; Huang Z; Wang Y; Deng W; Zheng S; Li T
Front Immunol; 2022; 13():914265. PubMed ID: 35874753
[TBL] [Abstract] [Full Text] [Related]
9. Down-regulation of circPTTG1IP induces hepatocellular carcinoma development via miR-16-5p/RNF125/jak1 axis.
Peng R; Cao J; Su BB; Bai XS; Jin X; Wang AQ; Wang Q; Liu RJ; Jiang GQ; Jin SJ; Zhang C; Bai DS
Cancer Lett; 2022 Sep; 543():215778. PubMed ID: 35710093
[TBL] [Abstract] [Full Text] [Related]
10. Laparoscopic liver resection for colorectal liver metastases: retrospective analysis of prognostic factors and oncological outcomes in a single-center cohort.
Taillieu E; De Meyere C; Nuytens F; Vanneste G; Libbrecht L; Alaerts H; Parmentier I; Verslype C; D'Hondt M
Langenbecks Arch Surg; 2022 Sep; 407(6):2399-2414. PubMed ID: 35499586
[TBL] [Abstract] [Full Text] [Related]
11. Effects of Vitexin, a Natural Flavonoid Glycoside, on the Proliferation, Invasion, and Apoptosis of Human U251 Glioblastoma Cells.
Huang J; Zhou Y; Zhong X; Su F; Xu L
Oxid Med Cell Longev; 2022; 2022():3129155. PubMed ID: 35281458
[TBL] [Abstract] [Full Text] [Related]
12. Kinase Inhibition as treatment for Acute and Chronic Graft-
Braun LM; Zeiser R
Front Immunol; 2021; 12():760199. PubMed ID: 34868001
[TBL] [Abstract] [Full Text] [Related]
13. CXCR4 allows T cell acute lymphoblastic leukemia to escape from jak1/2 and BCL2 inhibition through CNS infiltration.
Walker KL; Rinella SP; Hess NJ; Turicek DP; Kabakov SA; Zhu F; Bouchlaka MN; Olson SL; Cho MM; Quamine AE; Feils AS; Gavcovich TB; Rui L; Capitini CM
Leuk Lymphoma; 2021 May; 62(5):1167-1177. PubMed ID: 33843403
[TBL] [Abstract] [Full Text] [Related]
14. Therapeutic Efficacy of Combined jak1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms.
Rampal RK; Pinzon-Ortiz M; Somasundara AVH; Durham B; Koche R; Spitzer B; Mowla S; Krishnan A; Li B; An W; Derkach A; Devlin S; Rong X; Longmire T; Eisman SE; Cordner K; Whitfield JT; Vanasse G; Cao ZA; Levine RL
Clin Cancer Res; 2021 Jun; 27(12):3456-3468. PubMed ID: 33782031
[TBL] [Abstract] [Full Text] [Related]
15. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via jak1/STAT5 pathway in tumor microenvironment.
Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
[TBL] [Abstract] [Full Text] [Related]
16. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/jak1/STAT3 and NF-kB signaling pathways synergistically.
Zhang X; Hu B; Sun YF; Huang XW; Cheng JW; Huang A; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J; Yang XR
Clin Transl Med; 2021 Feb; 11(2):e335. PubMed ID: 33634982
[TBL] [Abstract] [Full Text] [Related]
17. Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of jak1/STAT3 and AKT signaling.
Wang H; Hou W; Perera A; Bettler C; Beach JR; Ding X; Li J; Denning MF; Dhanarajan A; Cotler SJ; Joyce C; Yin J; Ahmed F; Roberts LR; Qiu W
Cell Rep; 2021 Feb; 34(8):108765. PubMed ID: 33626345
[TBL] [Abstract] [Full Text] [Related]
18. Extract of
Huang X; Chen Y; Zhang X; Li F; Ye H
Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
[No Abstract] [Full Text] [Related]
19. Vitexin abrogates invasion and survival of hepatocellular carcinoma cells through targeting STAT3 signaling pathway.
Lee JH; Mohan CD; Shanmugam MK; Rangappa S; Sethi G; Siveen KS; Chinnathambi A; Alahmadi TA; Alharbi SA; Basappa S; Rangappa KS; Ahn KS
Biochimie; 2020 Aug; 175():58-68. PubMed ID: 32445654
[TBL] [Abstract] [Full Text] [Related]
20. Adipose Tissue-Derived Mesenchymal Stem Cells Suppress Growth of Huh7 Hepatocellular Carcinoma Cells via Interferon (IFN)-β-Mediated JAK/STAT1 Pathway
Byun CS; Hwang S; Woo SH; Kim MY; Lee JS; Lee JI; Kong JH; Bae KS; Park IH; Kim SH; Eom YW
Int J Med Sci; 2020; 17(5):609-619. PubMed ID: 32210710
[TBL] [Abstract] [Full Text] [Related]
[Next]
